FDA Logo links to FDA home pageCenter for Devices and Radiological Health, U.S. Food and Drug AdministrationHHS Logo links to Department of Health and Human Services website

FDA Home Page | CDRH Home Page | Search | CDRH A-Z Index | Contact CDRH U.S. Food and Drug Administration Center for Devices and Radiological Health [Skip navigation]
horizonal rule

Index of CDRH Web Documents

KEY: Links are numbered according to what type of file they point to. 1=Text, 2=PDF, 3=PowerPoint, 4=Word, 5=XML, 6=See Also. Topics starting with : 0-9  A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 
Or, enter a word or phrase to search for in document titles :
(Search Help)
Some additional items of interest can be found on the Consumer Information page.
 
Premarket Approval
* Blue Book Memoranda - PMA [Text]
* PMA Modular Submission Cover Sheet at HIMA Website   [PDF]
* 30-Day Notices and 135-Day PMA Supplements for Manufacturing Method or Process Changes (2/19/98) (P98-4) [Text]
* 30-Day Notices and 135-day PMA Supplements for Manufacturing Method or Process Changes, Guidance for Industry and CDRH (Docket 98D-0080); Final [Text] [PDF]
* 4-of-A-Kind PMAs   [PDF]
* A Pilot Program to Evaluate a Proposed Globally Harmonized Alternative for Premarket Procedures; Guidance for Industry and FDA Staff [Text] [PDF]
* Acceptance of Foreign Clinical Studies; Guidance for Industry [Text] [PDF]
* Bundling Multiple Devices or Multiple Indications in a Single Submission - Guidance for Industry and FDA Staff [Text] [PDF]
* Clinical Utility and Premarket Approval #P91-1 (blue book memo) [Text]
* Continued Access to Investigational Devices During PMA Preparation and Review (Blue Book Memo) (D96-1) [Text]
* Criteria for Panel Review of PMA Supplements #P86-3 (blue book memo) [Text]
* Device Advice: PMA Supplements and Amendments [Text]
* Distribution and Public Availability of PMA Summary of Safety and Effectiveness Data Packages [Text]
* Draft Guidance: Likelihood of Facilities Inspections When Modifying Devices Subject to Premarket Approval [Text] [PDF]
* Early Collaboration Meetings Under the FDA Modernization Act (FDAMA) (2/19/98 (P98-3) [Text]
* Expedited Review of Premarket Submissions for Devices - Guidance for Industry and FDA Staff [Text] [PDF]
* FDA and Industry Actions on Premarket Approval Applications (PMAs): Effect on FDA Review Clock and Performance Assessment - Guidance for Industry and FDA Staff [Text] [PDF]
* FDA Launches Initiative to Improve the Development and Availability of Innovative Medical Products [Text]
* Guidance on PMA Interactive Procedures for Day-100 Meetings and Subsequent Deficiencies (2/19/1998) (P98-2) [Text]
* Guidance on PMA Interactive Procedures for Day-100 Meetings and Subsequent Deficiencies - for Use by CDRH and Industry; Final [Text] [PDF]
* Guidance on Section 216 of the Food and Drug Administration Modernization Act of 1997 [Text] [PDF]
* Guidance to Industry Supplements to Approved Applications for Class III Medical Devices: Use of Published Literature, Use of Previously Submitted Materials, and Priority Review; Final [Text]
* Improving Innovation in Medical Technology: Beyond 2002 [Text]
* Improving Innovation in Medical Technology: Beyond 2002 - Executive Summary [Text]
* In Vitro Diagnostic Model for a Pilot for Streamlined PMA Review [Text]
* Information About Applications with a Link to Releasable PMAs [Text]
* Letter to IVD Manufacturers on Streamlined PMA; Final   [PDF]
* Modifications to Devices Subject to Premarket Approval - The PMA Supplement Decision Making Process; Draft   [PDF]
* New IDE / PMA Development and Review Model and Pilots [Text]
* New Model Medical Device Development Process; Final [Text]
* Panel Review of Premarket Approval Applications #P91-2 (blue book memo) [Text]
* PMA Compliance Program #P91-3 (blue book memo) [Text]
* PMA Review Schedules (P87-1) Replaced by P94-2 [Text]
* PMA Review Statistical Checklist   [PDF]
* PMA Supplements: ODEs letter to manufacturers; identifies situations which may require the submission of a PMA supplement (When PMA Supplements are Required) #P90-1 (blue book memo) [Text]
* PMA Transformation Team Home Page [Text]
* PMA/510(k) Triage Review Procedures #G94-1 (blue book memo) [Text]
* PMAs - Early Review and Preparation of Summaries of Safety and Effectiveness #P86-1 (blue book memo) [Text]
* Premarket Approval (PMA) Manual [Text] [PDF]
* Premarket Approval Application (PMA) Closure #P94-2 (blue book memo) [Text]
* Premarket Approval Application Content Shell [Text]
* Premarket Approval Application Filing Review - Guidance for Industry and FDA Staff [Text] [Text] [PDF]
   [PDF]
* Premarket Approval Application Modular Review - Guidance for Industry and FDA Staff [Text] [PDF]
* Premarket Approval Applications (PMA) for Absorbable Powder for Lubricating a Surgeon’s Glove - Guidance for Industry and FDA Staff [Text] [PDF]
* Premarket Approval Search Engine [Text]
* Premarket Assessment of Pediatric Medical Devices - Guidance for Industry and FDA Staff [Text] [PDF]
* Quality System Information for Certain Premarket Application Reviews; Guidance for Industry and FDA Staff   [PDF]
* Real-Time Review Program for Premarket Approval Application (PMA) Supplements [Text] [PDF]
* Review and Approval of PMAs of Licensees #P86-4 (blue book memo) [Text]
* SMDA Changes - PMA Manual Insert   [PDF]
* Threshold Assessment of the Impact of Requirements for Submission of PMAs for 31 Medical Devices Marketed Prior to May 28, 1976   [PDF]
* User Fees and Refunds for Premarket Approval Applications - Guidance for Industry and FDA Staff [Text] [PDF]
 

horizonal rule

CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page

Center for Devices and Radiological Health / CDRH